Page last updated: 2024-08-21

amiloride and Triple Negative Breast Neoplasms

amiloride has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Balza, E; Carlone, S; Carta, S; Castellani, P; Cossu, V; Marini, C; Piccioli, P; Rubartelli, A; Sambuceti, G	1

Other Studies

1 other study(ies) available for amiloride and Triple Negative Breast Neoplasms

Article	Year
Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer medicine, 2022, Volume: 11, Issue:1 Topics: Amiloride; Animals; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Cisplatin; Esomeprazole; Female; Humans; Hydrogen-Ion Concentration; Mice, Inbred BALB C; Proton Pump Inhibitors; Sodium-Hydrogen Exchanger 1; Triple Negative Breast Neoplasms; Tumor-Associated Macrophages; Vacuolar Proton-Translocating ATPases	2022

Article

Year

Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models.

Cancer medicine, 2022, Volume: 11, Issue:1

Topics: Amiloride; Animals; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Cisplatin; Esomeprazole; Female; Humans; Hydrogen-Ion Concentration; Mice, Inbred BALB C; Proton Pump Inhibitors; Sodium-Hydrogen Exchanger 1; Triple Negative Breast Neoplasms; Tumor-Associated Macrophages; Vacuolar Proton-Translocating ATPases

2022